PRECIOUS NEWS | ISSUE 6 | 02/2018
 
 
Link to website
 
 
PRECIOUS NEWS | ISSUE 6 | 02/2018
 
 

Content

Trial progress

PRECIOUS had a good start in the first weeks of 2018!

With the recent opening of our first site in Poland, the Institute of Psychiatry and Neurology in Warsaw, we now have sites open for recruitment in all 9 countries. We will still be opening sites in the coming weeks.


After their recent SIV (site initiating visit) Gloucestershire Royal Hospital and Royal Infirmary of Edinburgh (UK), Ospedale di Città della Pieve and Ospedale Gubbio-Gualdo Tadino (IT), Ioannina University Hospital and Larissa University Hospital (GR), received green light to start recruitment for PRECIOUS. Larissa University Hospital (GR) recruited their first two patients within weeks after the SIV.


Also Sykehuset Telemark Notodden (NO) and Royal Hallamshire Hospital (UK) recently recruited their first patients.

Top 3 recruiting centers in December 2017 and January 2018*

1. Four patients per site: Royal Hallamshire Hospital, UK (total: 4 patients) and Kings College Hospital, UK (total: 6 patients)

2. Three patients per site: Nottingham University Hospital, UK (total: 5 patients) and Haaglanden Medisch Centrum, NL (total: 12 patients)

3. Two patients per site: Larissa University Hospital, GR (total: 3 patients)

 

* With the exception of UMC Utrecht

Top 5 recruiting centers overall

1. University Medical Center Utrecht, NL (44 patients)

2. Haaglanden Medisch Centrum, NL (12 patients)

3. ASST di Mantova, IT (6 patients)

4. Kings College Hospital, UK (6 patients)

5. Neurologische Klinik Tubingen, University Medical Center Hamburg Eppendorf, DE, and Elisabeth-Tweesteden Ziekenhuis, NL (5 patients)

 

Total number of patients included: 123

 

 

 

Contact

Coordinator

University Medical Center Utrecht, The Netherlands
Dr. Bart van der Worp

Project Management

ARTTIC, Germany
Sophie Rau

 

Follow us on Twitter!
 
 
PRECIOUS has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634809.
The views expressed here are the responsibility of the authors only. The EU Commission takes no responsibility for any use made of the information set out.		 Copyright | Imprint PRECIOUS has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634809.<br>The views expressed here are the responsibility of the authors only. The EU Commission takes no responsibility for any use made of the information set out.
 

If you no longer wish to receive our newsletter please click here to unsubscribe.

Having trouble viewing this email? Click here to view it in your browser.